Session ID: 
TH4

Direct-to-Consumer Asynchronous Telemedicine: Consumerism is Here to Stay

1:15pm - 2:15pm Monday, March 9
Orlando - Orange County Convention Center
W414C
Additional Registration
Extra Fee

Description

Direct-to-consumer telemedicine, including telemedicine performed asynchronously, is a growing field demanded by patients and consumers. When done right, this modality of care can transform the health care system for the better - allowing patients to get the care they need when and where they need it. However, unscrupulous actors, such as call centers or those attempting to defraud public programs like Medicare and Medicaid, tend to claim they are practicing 'telemedicine'. How are the good actors following the law and transforming the system? How can they be distinguished from the bad actors? At the end of the day, consumer demand is going to drive expansion of more convenient and accessible care, so we need to pave the way for its success.
This session is part of a special program called Telehealth Symposium. Extra fees and separate registration is required.

Learning Objectives

  • Define direct-to-consumer and asynchronous telemedicine
  • Identify differences between appropriate direct-to-consumer telemedicine and fraud that should not be considered telemedicine
  • Outline activities for the industry to advance direct-to-consumer telemedicine

Speaker(s)

Chief Executive Officer,
Zipnosis, Inc.
Director,
Faegre Baker Daniels LLP

Continuing Education Credits

CPHIMS
1.00

Audience

CIO/CTO/CTIO/Senior IT

Level

Intermediate